373 THE EVALUATION OF EFFECTIVENESS AND SAFETY FOR NEW THERAPY WITH BONE MARROW DERIVED AUTOLOGOUS MESENCHYMAL STEM CELL FOR HEPATIC FAILURE CAUSED BY ALCOHOLIC LIVER CIRRHOSIS; PHASE II STUDY